Skip to main content
The global urology surgical instruments market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, growing at a CAGR of 8.2% from 2016 to 2021. The growth of the overall urology surgical instruments market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population.

However, High cost of urology endoscopes and endovision systems, and unfavorable healthcare reforms in the U.S. is expected to restrain the growth of this market to a certain extent. Moreover, the growing healthcare market in emerging economies, and increasing number of free-trade agreements are expected to provide growth opportunities for players operating in this market.
In the coming years, North America is expected to account for the largest share of the urology surgical instruments market. Factors such as the favorable reimbursement scenario and government initiatives to combat prostate cancer in the U.S., investments by hospitals to upgrade surgical/operating rooms and purchase new urology surgical equipment, and increase in the number of ambulatory surgical centers (ASCs) in the U.S., high incidence rate of urological cancer and the new funding model for Canadian hospitals are contributing to the large share of the North American region.

However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period (2016-2021). The high growth of this region can be attributed to favorable prospects for the growth of the urology surgical instruments market, growing healthcare industry in Japan, government investments to improve the medical infrastructure, penetration of key players in the Chinese market, growing preference for minimally invasive surgeries & improving healthcare infrastructure, German-Asian partnerships stimulating market growth, Asian countries leading medical tourism destinations, growing number of hospitals in Singapore and South Korea, and favorable healthcare system in Australia are expected to propel the urology surgical instruments market in the Asia-Pacific region.

Read expert analysis about the global Urology Surgical Instruments Market by product and application.
https://www.marketsandmarkets.com/Market-Reports/urology-surgical-instrument-market-120080018.html

( Source: https://listnewpress.wordpress.com/2019/01/28/urology-surgical-instruments-market-by-product-future-growth-share )

Comments

Popular posts from this blog

Top 10 Medical Device Technologies Which Booming in 2019

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IV

In Situ Hybridization Market Growth Analysis - Global Forecast To 2021

According to the new market research report  " In situ Hybridization Market  by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected to account for the largest share of the global market. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, g

Home Healthcare Market - Global Forecast to 2022 | CAGR of 8.8%

According to the new market research report " Home Healthcare Market  by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. Don’t miss out on business opportunities in Home Healthcare Market . Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=696 The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 220.67 Billion in 2016, at a CAGR of 8.8%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The objectives of this study are as follows: To define, describe, segment and forecast the